MicroRNAs in cardiac hypertrophy and failure

Drug Discovery Today: Disease Mechanisms

Volumn 5, Issue 3-4, 2008, Pages

  Thum, Thomas ^a,b   Bauersachs, Johann ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR AGENT; MICRORNA; MICRORNA ANTAGONIST; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

CELL GROWTH; CELL MATURATION; CELL TYPE; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HUMAN; IN VIVO STUDY; NONHUMAN; PROTEIN TARGETING; REVIEW; RNA TRANSLATION; VALIDATION PROCESS;

EID: 67649403443     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2008.07.002     Document Type: Review

References (38)

1. Ambros V. The functions of animal microRNAs. Nature 431 (2004) 350-355
2. Shyu A.B., et al. Messenger RNA regulation: to translate or to degrade. EMBO J. 27 (2008) 471-481
3. Lee Y., et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 425 (2003) 415-419
4. Hutvagner G., et al. A cellular function for the RNA-interference enzyme dicer in the maturation of the let-7 small temporal RNA. Science 293 (2001) 834-838
5. Valencia-Sanchez M.A., et al. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev. 20 (2006) 515-524
6. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 (2004) 281-297
7. Bauersachs J., and Thum T. MicroRNAs in the broken heart. Eur. J. Clin. Invest. 37 (2007) 829-833
8. Rhoades M.W., et al. Prediction of plant microRNA targets. Cell 110 (2002) 513-520
9. Jopling C.L., et al. Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 309 (2005) 1577-1581
10. Wienholds E., et al. MicroRNA expression in zebrafish embryonic development. Science 309 (2005) 310-311
11. Esquela-Kerscher A., and Slack F.J. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 6 (2006) 259-269
12. He L., et al. A microRNA component of the p53 tumour suppressor network. Nature 447 (2007) 1130-1134
13. Thum T., et al. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 116 (2007) 258-267
14. Chen J.F., et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 38 (2006) 228-233
15. Zhao Y., et al. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436 (2005) 214-220
16. Zhao Y., et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129 (2007) 303-317
17. Care A., et al. MicroRNA-133 controls cardiac hypertrophy. Nat. Med. 13 (2007) 613-618
18. van Rooij E., et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. PNAS 103 (2006) 18255-18260
19. van Rooij E., et al. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316 (2007) 575-579
20. Hill J.A., and Olson E.N. Cardiac plasticity. N. Engl. J. Med. 358 (2008) 1370-1380
21. Cheng Y.H., et al. MicroRNAs are aberrantly expressed in hypertrophic heart - do they play a role in cardiac hypertrophy?. Am. J. Pathol. 170 (2007) 1831-1840
22. Sayed D., et al. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ. Res. 100 (2007) 416-424
23. Tatsuguchi M., et al. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J. Mol. Cell. Cardiol. 42 (2007) 1137-1141
24. Ikeda S., et al. Altered microRNA expression in human heart disease. Physiol. Genomics. (2007) 00144
25. Sucharov C., et al. miRNA expression in the failing human heart: functional correlates. J. Mol. Cell. Cardiol. 45 (2008) 185-192
26. Catalucci D., et al. Physiological myocardial hypertrophy: how and why?. Front Biosci. 13 (2008) 312-324
27. Harris T.A., et al. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. PNAS 105 (2008) 1516-1521
28. Urbich C., et al. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc. Res. (2008) cvn156
29. Lai E.C. Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation. Nat. Genet. 30 (2002) 363-364
30. Lewis B.P., et al. Prediction of mammalian microRNA targets. Cell 115 (2003) 787-798
31. Yang B., et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat. Med. 13 (2007) 486-491
32. Thum T., et al. MicroRNAs: novel regulators in cardiac development and disease. Cardiovasc. Res. 79 (2008) 562-570
33. Xiao J., et al. MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts. J. Biol. Chem. 282 (2007) 12363-12367
34. Xiao J., et al. Novel approaches for gene-specific interference via manipulating actions of microRNAs: examination on the pacemaker channel genes HCN2 and HCN4. J. Cell Physiol. 212 (2007) 285-292
35. Luo X., et al. Downregulation of MIRNA-1/MIRNA-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart. J. Biol. Chem. (2008) M801035200
36. Krutzfeldt J., et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438 (2005) 685-689
37. Kim V.N. MicroRNA biogenesis: coordinated cropping and dicing. Nat. Rev. Mol. Cell. Biol. 6 (2005) 376-385
38. Ebert M.S., et al. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Methods 4 (2007) 721-726